Yes, the market showed significant weakness last week for the first time in quite a while. In fact, the Dow Jones Industrial Average moved triple digits each day. But it was all quite predictable, as ...
Viking Therapeutics (VKTX): New IPO going public Thursday, September 18, 2014. Overview VKTX is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or ...
The 2014 Q2 earnings season has been impressive for the Medical sector with 16.1% year-over-year earnings growth on 12.5% increase in revenues. Also, among the 94% sector participants reported so far,...
Johnson & Johnson (NYSE:JNJ), which is one of my favorite long-term stocks for income and dividend-reinvesting investors, just dropped below the $100.00-per-share level and is becoming more attractive...
Add a Comment